pharma · Asthma · Multiple Sclerosis · TEVA
Teva Pharma
Teva Pharma GmbH
Teva Biotech is a pharma organization headquartered in TEL AVIV, DE. It trades on NYSE under ticker TEVA. Primary therapeutic focus areas include Asthma, Multiple Sclerosis, Pain, Crohn's Disease, Seasonal Allergic Rhini
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV HQ
126 Employees
Public company Type
TEVA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
- Employees
- 126
- Programs
- 473
- Drugs
- 447
- Patents
- 454
Delayed Release 6MP or Calcitriol vs. Purinethol
Phase 2 · small molecule · Crohn's Disease
Delayed Release 6MP or Calcitriol vs. Purinethol for Crohn's Disease is a Phase 2 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Internal code C2/13/6MP:CAL-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Teva Pharma GmbH
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Crohn's Disease
- Status
- completed
- Trials
- 1